Chryselys

Palo Alto, United States Founded: 2019 • Age: 7 yrs
Offers data solutions for clinical trials, market access, and sales strategies.

About Chryselys

Chryselys is a Healthcare company based in Palo Alto (United States) founded in 2019. It offers data solutions for clinical trials, market access, and sales strategies. It operates on a B2B and SaaS model. The company has 80 employees. Its Indian entity Chryselys Services Private Limited reported revenue of β‚Ή22.11 Cr. Chryselys offers products and services including Principal Investigator Targeting, REDPlanUP, Key Influencer Targeting, DataFusionIQ, and Payer Intelligence. Its focus areas include Market Access, Sales, Physician Targeting and Data Analytics. Its competitors include Target RWE, Secura Bio and STATinMED Research; 1 of its 3 listed competitors has raised funding.

Company details

Chryselys converts complex pharmaceutical data into actionable insights using AI and technology, supporting partners in healthcare. They provide solutions for data analytics, clinical development, and sales planning to accelerate trials and improve patient outcomes. Based in the US and India, they focus on connecting physicians and driving business impact through adaptable strategies.

Key Metrics
  • Indian entity revenue
    ₹22.11 Cr

    FY 2024 · +103% YoY

  • Indian entity net profit
    ₹1.94 Cr

    FY 2024 · 9% margin

  • Indian entity EBITDA
    ₹2.98 Cr

    FY 2024 · 13% margin

  • Employee Count
    80

Products & Services of Chryselys

Chryselys offers a comprehensive portfolio of products and services, including Principal Investigator Targeting, REDPlanUP, Key Influencer Targeting, DataFusionIQ, and Payer Intelligence.

Principal Investigator Targeting
Data Analytics Tool

Accelerates trial recruitment by partnering with key physicians.

REDPlanUP
Diversity Tool

Ensures patient equity in clinical trials with diverse mixes.

Key Influencer Targeting
Networking Platform

Connects businesses with physicians for impactful decisions.

DataFusionIQ
Data Integration

Provides repository for patient data to solve challenges.

Payer Intelligence
Market Tool

Analyzes payer landscapes to reduce socioeconomic burdens.

Board of directors of Chryselys Services Private Limited (Chryselys)

Chryselys Services Private Limited is the primary company behind Chryselys. The board of Chryselys Services Private Limited currently have 3 directors; the longest-serving is Gopal Krishan Khanna, appointed in 2021. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Gopal Krishan Khanna
DIN 09400166
Director15 Nov 20214 yrs 11 moChryselys Services Private Limited
Deviprasad Jagatpal Singh
DIN 10383379
Director16 Nov 20232 yrs 11 moChryselys Services Private Limited
Nagarajan Anantha Krishna
DIN 11319374
Additional Director27 Sep 20251 yr 1 moChryselys Services Private Limited

People of Chryselys

8 people are tracked at Chryselys (4 in leadership, 4 in team); the tracked headcount is 80.

NameRoleGroup
Chief Operating OfficerLeadership
Ashley Peterson
Director Of Sales And Business DevelopmentLeadership
Amit A.
Head Of Talent Acquisition And Talent ManagementLeadership
Soundarya Lakshmi
Talent PartnerLeadership
Rakesh Kumar
Talent AcquisitionTeam
Bharathi Dhakshinamoorthy
Analyst - Talent AcquisitionTeam
Sudharsan Mohan
Group Lead - Products & Site Lead - ChennaiTeam
Archana Sai
Inside Sales ConsultantTeam
Premium access

Complete people profiles for Chryselys

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Chryselys

Figures of Chryselys Services Private Limited, the primary company behind Chryselys, for FY 2024. Revenue was ₹22.11 Cr (+103% year on year). Net profit was ₹1.94 Cr (9% margin). EBITDA was ₹2.98 Cr (13% margin).

  • ₹22.11 CrRevenue · FY 2024 · +103% YoY
  • ₹1.94 CrNet profit · 9% margin
  • ₹2.98 CrEBITDA · 13% margin
  • ₹1 LakhPaid-up capital
  • 80Employees (provident fund records)

Balance sheet, profit and loss, cash flow and ratios of Chryselys Services Private Limited are on its company page.

Premium access

Detailed financial statements for Chryselys

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Chryselys

Chryselys has 3 listed competitors in our database, 1 of them funded. They include Target RWE, Secura Bio and STATinMED Research.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
targetrwe.com2017Durham, United States116
Marketing services to the pharmaceutical industry are provided.
securabio.com2018Henderson, United States$55M
Consulting services for market access and health outcomes are provided.
statinmed.com2007Ann Arbor, United States
Healthcare data analytics services provider
Premium access

Detailed competitors of Chryselys

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Pharmaceuticals & Distribution

3 companies that operate in the same segment as Chryselys (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
2014New York, New York, United StatesUSD 1.3 BUSD 8.26 M750
Developer of pharmaceutical products for treating multiple diseases
1980Thousand Oaks, California, United StatesUSD 33.23 B28,000
Biopharmaceutical research and drug development are conducted globally by AbbVie.
2012Chicago, Illinois, United StatesUSD 61.16 B55,000
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Chryselys

Chryselys was founded in 2019.

Chryselys is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.

Chryselys has 80 employees.

The primary company behind Chryselys, Chryselys Services Private Limited, reported revenue of β‚Ή22.11 Cr for FY 2024, up 103% year on year.

Chryselys converts complex pharmaceutical data into actionable insights using AI and technology, supporting partners in healthcare. They provide solutions for data analytics, clinical development, and sales planning to accelerate trials and improve patient outcomes. Based in the US and India, they focus on connecting physicians and driving business impact through adaptable strategies.

Chryselys's top competitors include Target RWE, STATinMED Research and Secura Bio.

Chryselys offers Principal Investigator Targeting, REDPlanUP, Key Influencer Targeting, DataFusionIQ, and Payer Intelligence.

Chryselys operates through Chryselys Services Private Limited.

The legal entities of Chryselys currently have 3 directors, including Gopal Krishan Khanna, Nagarajan Anantha Krishna, Deviprasad Jagatpal Singh.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available